Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$42.3M |
| 2 |
United Parcel Service
UPS
|
+$34.7M |
| 3 |
Lumen
LUMN
|
+$28.1M |
| 4 |
Invitation Homes
INVH
|
+$26.7M |
| 5 |
Progressive
PGR
|
+$25.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$90.4M |
| 2 |
Dell
DELL
|
+$67.6M |
| 3 |
LVLT
Level 3 Communications Inc
LVLT
|
+$64.9M |
| 4 |
AT&T
T
|
+$36.5M |
| 5 |
Automatic Data Processing
ADP
|
+$35.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.06% |
| 2 | Healthcare | 14.62% |
| 3 | Consumer Discretionary | 11.07% |
| 4 | Industrials | 10.59% |
| 5 | Communication Services | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
KB Home
KBH
$3.47B
| $4.13M | ﹤0.01% |
129,400
+3,700
| +3% | +$106K |
|
1177
Minerals Technologies
MTX
$2.32B
| $4.12M | ﹤0.01% |
59,800
+1,300
| +2% | +$92.4K |
|
1178
New York Times
NYT
$10.5B
| $4.12M | ﹤0.01% |
222,500
+6,800
| +3% | +$126K |
|
1179
Compass Minerals
CMP
$1.13B
| $4.11M | ﹤0.01% |
56,850
| – | – |
|
|
CPE
1180
DELISTED
Callon Petroleum Company
CPE
| $4.11M | ﹤0.01% |
33,800
| – | – |
|
|
AHL
1181
DELISTED
ASPEN Insurance Holding Limited
AHL
| $4.11M | ﹤0.01% |
101,100
+1,900
| +2% | +$78.6K |
|
|
WLL
1182
DELISTED
Whiting Petroleum Corporation
WLL
| $4.09M | ﹤0.01% |
2,059
+45
| +2% | +$79K |
|
1183
Liberty Latin America Class C
LILAK
$1.65B
| $4.09M | ﹤0.01% |
240,065
+5,257
| +2% | +$98.9K |
|
1184
Ormat Technologies
ORA
$6.87B
| $4.08M | ﹤0.01% |
63,834
+1,300
| +2% | +$82.5K |
|
|
KW
1185
DELISTED
Kennedy-Wilson Holdings
KW
| $4.08M | ﹤0.01% |
235,268
+72,168
| +44% | +$1.36M |
|
1186
Chord Energy
CHRD
$7.8B
| $4.08M | ﹤0.01% |
485,250
+107,400
| +28% | +$990K |
|
|
ELME
1187
Elme Communities
ELME
$144M
| $4.08M | ﹤0.01% |
131,000
+2,600
| +2% | +$84.4K |
|
1188
Myriad Genetics
MYGN
$311M
| $4.07M | ﹤0.01% |
118,500
+3,900
| +3% | +$132K |
|
1189
Prestige Consumer Healthcare
PBH
$2.51B
| $4.06M | ﹤0.01% |
91,500
+2,900
| +3% | +$132K |
|
|
HZNP
1190
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.06M | ﹤0.01% |
278,156
+7,800
| +3% | +$110K |
|
|
LEXEA
1191
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $4.06M | ﹤0.01% |
91,523
+1,400
| +2% | +$67.2K |
|
|
CCMP
1192
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $4.05M | ﹤0.01% |
43,100
+1,400
| +3% | +$129K |
|
1193
Pan American Silver
PAAS
$21.8B
| $4.05M | ﹤0.01% |
259,600
+5,000
| +2% | +$79.2K |
|
1194
MillerKnoll
MLKN
$1.64B
| $4.04M | ﹤0.01% |
100,800
+2,200
| +2% | +$77.2K |
|
1195
Old National Bancorp
ONB
$10.1B
| $4.03M | ﹤0.01% |
230,784
+5,600
| +2% | +$101K |
|
1196
AMN Healthcare
AMN
$1.42B
| $4.02M | ﹤0.01% |
81,700
+2,500
| +3% | +$114K |
|
1197
Carpenter Technology
CRS
$27.8B
| $4.02M | ﹤0.01% |
78,800
| – | – |
|
1198
FirstService
FSV
$6.27B
| $4.02M | ﹤0.01% |
57,400
| – | – |
|
1199
First Financial Bankshares
FFIN
$4.93B
| $4.01M | ﹤0.01% |
178,000
| – | – |
|
1200
HealthEquity
HQY
$8.93B
| $4.01M | ﹤0.01% |
85,900
+1,800
| +2% | +$89.1K |
|
Similar funds
Swiss National Bank's Q4 2017 Portfolio in Review
As of Q4 2017, Swiss National Bank held 2,605 positions worth $92.6B, up 5.4% from $87.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Swiss National Bank's Q4 2017 filing shows 77 new, 1,182 increased, 249 reduced and 91 closed positions. Its largest new stake was Invitation Homes: 1,152,016 shares worth $27.2M. The largest sale was CR Bard Inc., an estimated $90.4M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q4 2017 buy was Invitation Homes: 1,152,016 shares worth $27.2M.
- Swiss National Bank added most to Amphenol in Q4 2017, an estimated $42.3M increase.
- Swiss National Bank's biggest Q4 2017 reduction was Dell, cutting an estimated $67.6M.
- Swiss National Bank fully exited CR Bard Inc. in Q4 2017, selling an estimated $90.4M.
- Swiss National Bank's ten largest holdings make up 17% of its $92.6B portfolio in Q4 2017.
- Swiss National Bank opened 77 new positions and closed 91 in Q4 2017.
- Swiss National Bank's portfolio value rose 5.4% quarter-over-quarter to $92.6B.
Based on Swiss National Bank's 13F filing for Q4 2017, filed 7 Feb 2018.